Carmignac Gestion Olink Holding Ab (Publ) Transaction History

Carmignac Gestion

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$21.87 - $25.59 $1.17 Million - $1.36 Million	53,293 Added 32.29%	218,329 $5.56 Million
Q1 2024 May 14, 2024	BUY	$21.81 - $25.14 $907,644 - $1.05 Million	41,616 Added 33.72%	165,036 $3.88 Million
Q4 2023 Feb 13, 2024	BUY	$14.29 - $25.95 $1.76 Million - $3.2 Million	123,420 New	123,420 $3.1 Million
Q1 2022 May 13, 2022	SELL	$11.33 - $19.3 $2.28 Million - $3.89 Million	-201,489 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$18.0 - $34.82 $2.1 Million - $4.07 Million	-116,929 Reduced 36.72%	201,489 $3.67 Million
Q3 2021 Nov 12, 2021	BUY	$23.42 - $37.93 $7.46 Million - $12.1 Million	318,418 New	318,418 $7.72 Million
Q2 2021 Aug 13, 2021	SELL	$26.65 - $39.47 $2.67 Million - $3.95 Million	-100,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.9 - $36.0 $3.19 Million - $3.6 Million	100,000 New	100,000 $3.6 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.